Medicalgorithmics India Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 3.44 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6.05%
- Profit Growth -413.39%
- Ebitda -641.19%
- Net Worth -34.63%
- Total Assets -30.35%
About Medicalgorithmics India
Medicalgorithmics India Private Limited (MIPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 July 2018 (Six years and seven months 5 days old ). Its registered office is in Koramangala, Bangalore, Karnataka, India.
The Corporate was formerly known as Algotel Solutions Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.44 M, as per Ministry of Corporate Affairs (MCA) records.
Jerzakowski Krzysztof, Balasubramanian Chandran, and Kailas Sringeri serve as directors at the Company.
Company Details
-
Location
Koramangala, Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33208KA2018PTC114711
-
Company No.
114711
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jul 2018
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Medicalgorithmics India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balasubramanian Chandran
|
Director | 12-Jul-2018 | Current |
|
Kailas Sringeri
|
Director | 12-Jul-2018 | Current |
Jerzakowski Krzysztof
|
Additional Director | 24-Oct-2018 | Current |
Financial Performance of Medicalgorithmics India.
Medicalgorithmics India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.05% increase. The company also saw a substantial fall in profitability, with a 413.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicalgorithmics India?
In 2023, Medicalgorithmics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medicalgorithmics India?
Unlock and access historical data on people associated with Medicalgorithmics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicalgorithmics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicalgorithmics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.